I. Caesar
- Genetics top 5%
- Epidemiology top 10%
- Surgery
- Immunology
- Gastroenterology top 10%
- Co-authors
- Tilo AndusJürgen SchölmerichMichael RothVolker GroßM GierendStefan FeuerbachA. GeißlerFrank Kullmann
- Topics
- Inflammatory Bowel Disease (12 papers)Microscopic Colitis (9 papers)Eosinophilic Esophagitis (4 papers)
- Cited by
- GeneticsGastroenterologyEpidemiology
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
I. Caesar
16 papers receiving 552 citations
Peers
Comparison fields: 5 of 73
- Genetics 385
- Epidemiology 297
- Surgery 153
- Immunology 122
- Gastroenterology 57
Countries citing papers authored by I. Caesar
This map shows the geographic impact of I. Caesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Caesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Caesar more than expected).
Fields of papers citing papers by I. Caesar
This network shows the impact of papers produced by I. Caesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Caesar. The network helps show where I. Caesar may publish in the future.
Co-authorship network of co-authors of I. Caesar
This figure shows the co-authorship network connecting the top 25 collaborators of I. Caesar. A scholar is included among the top collaborators of I. Caesar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Caesar. I. Caesar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group. | 20 |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 2 | |
| 8 | Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. | 18 |
| 9 | Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. | 83 |
| 10 | 19 | |
| 11 | 93 | |
| 12 | 1 | |
| 13 | Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group. | 11 |
| 14 | 29 | |
| 15 | 250 | |
| 16 | [Transitory increase of the thyroid stimulating hormone in the newborn after polyvinylpyrrolidon-iodine application during parturition (author's transl)]. | 2 |
About I. Caesar
I. Caesar is a scholar working on Gastroenterology, Genetics and Epidemiology, having authored 16 papers that have together received 572 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (4 papers). The work is most often cited by research in Genetics (385 citations), Gastroenterology (57 citations) and Epidemiology (297 citations). I. Caesar has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Tilo Andus, Jürgen Schölmerich, Michael Roth, Volker Groß, M Gierend, Stefan Feuerbach, A. Geißler, Frank Kullmann, Audrey Weber and K. Ewe. Their work appears in journals such as The Lancet, Gastroenterology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.